An increasing number of decision makers now require health economic support for reimbursing and listing new products, specifically in relation to their impact at the local level. More
The relationship between a cutting-edge technology and the venture capital industry is said to make or break the technology. The key question to be answered is: has Australia made the VC-Biotech relationship work? More
A recent high-level seminar on the European approach to financing innovative SMEs examined problems and best practices for companies and investors. More
A growing range of policies aimed specifically at protecting businesses from loss or damage to their intellectual property is now available and many businesses should consider whether such a policy is appropriate for them. More